US Stock MarketDetailed Quotes

Lixte Biotechnology (LIXT)

Watchlist
  • 3.350
  • +0.190+6.01%
Close Jan 22 16:00 ET
  • 3.350
  • 0.0000.00%
Post 16:04 ET
29.16MMarket Cap-2.82P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lixte Biotechnology (LIXT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
83.20%1.8M
-23.22%774.81K
-26.88%706.94K
-29.81%3.57M
-40.20%613.5K
-4.00%983.26K
-39.57%1.01M
-29.43%966.88K
-19.35%5.09M
-37.16%1.03M
Selling and administrative expenses
181.63%1.75M
-10.56%714.16K
-27.40%615.48K
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
-General and administrative expense
181.63%1.75M
-10.56%714.16K
-27.40%615.48K
-32.10%2.85M
-34.01%578.67K
-30.29%621.63K
-35.74%798.45K
-28.22%847.82K
-15.52%4.19M
-25.63%876.84K
Research and development costs
-85.98%50.7K
-71.22%60.65K
-23.19%91.46K
-19.14%726.23K
-76.64%34.83K
172.96%361.63K
-50.71%210.71K
-37.03%119.06K
-33.44%898.1K
-67.14%149.07K
Operating profit
-83.20%-1.8M
23.22%-774.81K
26.88%-706.94K
29.81%-3.57M
40.20%-613.5K
4.00%-983.26K
39.57%-1.01M
29.43%-966.88K
19.35%-5.09M
37.16%-1.03M
Net non-operating interest income expense
923.97%3.97K
24.78%-1.45K
37.74%-2.69K
-879.97%-9.77K
36.86%-3.91K
-92.98%388
-350.78%-1.92K
-474.96%-4.33K
-45.99%1.25K
-285.04%-6.2K
Non-operating interest income
208.28%4.43K
-83.65%365
-84.58%441
-59.69%7.05K
-86.85%519
-75.26%1.44K
-17.72%2.23K
-42.99%2.86K
56.19%17.49K
-43.47%3.95K
Non-operating interest expense
-56.43%457
-56.43%1.81K
-56.37%3.14K
3.62%16.82K
-56.31%4.43K
275.99%1.05K
113.24%4.15K
86.12%7.19K
82.91%16.23K
179.09%10.15K
Other net income (expense)
-5,689.84%-183.02K
267.72%581
168.10%79
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
Gain on sale of security
-5,689.84%-183.02K
267.72%581
168.10%79
-274.16%-3.4K
-91.89%-284
-2,800.00%-3.16K
-81.98%158
-108.70%-116
157.91%1.95K
92.73%-148
Income before tax
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Income tax
Net income
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Net income continuous Operations
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Minority interest income
Net income attributable to the parent company
-100.85%-1.98M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Preferred stock dividends
50.37K
Other preferred stock dividends
Net income attributable to common stockholders
-105.95%-2.03M
23.27%-775.67K
26.95%-709.56K
29.51%-3.59M
40.16%-617.69K
3.21%-986.03K
39.41%-1.01M
28.98%-971.32K
19.41%-5.09M
36.72%-1.03M
Basic earnings per share
25.00%-0.33
35.56%-0.29
32.56%-0.29
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
Diluted earnings per share
25.00%-0.33
35.56%-0.29
32.56%-0.29
40.23%-1.59
34.15%-0.27
10.20%-0.44
55.00%-0.45
47.56%-0.43
33.33%-2.66
58.16%-0.41
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 83.20%1.8M-23.22%774.81K-26.88%706.94K-29.81%3.57M-40.20%613.5K-4.00%983.26K-39.57%1.01M-29.43%966.88K-19.35%5.09M-37.16%1.03M
Selling and administrative expenses 181.63%1.75M-10.56%714.16K-27.40%615.48K-32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K
-General and administrative expense 181.63%1.75M-10.56%714.16K-27.40%615.48K-32.10%2.85M-34.01%578.67K-30.29%621.63K-35.74%798.45K-28.22%847.82K-15.52%4.19M-25.63%876.84K
Research and development costs -85.98%50.7K-71.22%60.65K-23.19%91.46K-19.14%726.23K-76.64%34.83K172.96%361.63K-50.71%210.71K-37.03%119.06K-33.44%898.1K-67.14%149.07K
Operating profit -83.20%-1.8M23.22%-774.81K26.88%-706.94K29.81%-3.57M40.20%-613.5K4.00%-983.26K39.57%-1.01M29.43%-966.88K19.35%-5.09M37.16%-1.03M
Net non-operating interest income expense 923.97%3.97K24.78%-1.45K37.74%-2.69K-879.97%-9.77K36.86%-3.91K-92.98%388-350.78%-1.92K-474.96%-4.33K-45.99%1.25K-285.04%-6.2K
Non-operating interest income 208.28%4.43K-83.65%365-84.58%441-59.69%7.05K-86.85%519-75.26%1.44K-17.72%2.23K-42.99%2.86K56.19%17.49K-43.47%3.95K
Non-operating interest expense -56.43%457-56.43%1.81K-56.37%3.14K3.62%16.82K-56.31%4.43K275.99%1.05K113.24%4.15K86.12%7.19K82.91%16.23K179.09%10.15K
Other net income (expense) -5,689.84%-183.02K267.72%581168.10%79-274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-148
Gain on sale of security -5,689.84%-183.02K267.72%581168.10%79-274.16%-3.4K-91.89%-284-2,800.00%-3.16K-81.98%158-108.70%-116157.91%1.95K92.73%-148
Income before tax -100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Income tax
Net income -100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Net income continuous Operations -100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Minority interest income
Net income attributable to the parent company -100.85%-1.98M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Preferred stock dividends 50.37K
Other preferred stock dividends
Net income attributable to common stockholders -105.95%-2.03M23.27%-775.67K26.95%-709.56K29.51%-3.59M40.16%-617.69K3.21%-986.03K39.41%-1.01M28.98%-971.32K19.41%-5.09M36.72%-1.03M
Basic earnings per share 25.00%-0.3335.56%-0.2932.56%-0.2940.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.41
Diluted earnings per share 25.00%-0.3335.56%-0.2932.56%-0.2940.23%-1.5934.15%-0.2710.20%-0.4455.00%-0.4547.56%-0.4333.33%-2.6658.16%-0.41
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +4.65%
Sample Name
Sample Code
 +4.15%
Sample Name
Sample Code
 +2.94%
4
Clean Energy Fuels
CLNE
+2.70%
5
American Express
AXP
+2.34%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +24.00%
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +7.44%
4
KE Holdings
BEKE
+5.08%
5
NIO Inc
NIO
+4.61%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -